ELYSIUM CELL BIO ITA
SOCIAL
ADDRESS
via Gaetano Salvatore, 486
Napoli
80145
Italia
Presso CEINGE Biotecnologie Avanzate Franco Salvatore scarl
P.I. 10204541212
ELYSIUM CELL BIO ITA
– SPIN-OFF FEDERICO II NAPLES | NUTRACEUTICALS & DIAGNOSTICS INNOVATIVE ANTIVIRAL AND CANCER DRUGS
Elysium Cell Bio Ita, an accredited academic spin-off of the University Federico II of Naples (Italy) bridges cutting-edge laboratory research with real-world applications, delivering innovative solutions to address unmet clinical needs. Guided by a team of experts in genetics, genomics, and translational clinical research, Elysium ensures that every breakthrough is supported by rigorous clinical studies, advancing human health. Elysium develops innovative solutions in the fields of health and wellness, specializing in anti-aging nutraceutical products, bio-regenerating cosmetics, and skin supplements designed to promote overall skin health and vitality. The company also focuses on advanced genetic diagnostic kits for applications in virology and oncology research, providing cutting-edge tools to improve disease detection and treatment. Additionally, Elysium is engaged in the development of new diagnostic kits, nutraceutical and pharmaceutical products, further contributing to advancements in medical science and personalized healthcare.
"The Innovative research addressing unmet clinical needs."
Motto: "Elysium, un idea italiana di benessere"
DIAGNOSTICS VIRAL KIT
DIAGNOSTIC KITS -Virology
We develop a NAT KIT-CE-IVD in collaboration with CEINGE Biotecnologie Avanzate "Franco Salvatore" and BioMol laboratories (Naples) . This KIT identify the "Spreaders" , SARS-CoV-2 patients infected which can still spread the viruses . This is a patent discovery analyzing the expression of the subgenomic N (sg-N) , ORF1a/b, E and RNAase P in naso-oropharyngeal swab.
A COLLABORATIVE EFFORT TO FIND A DIAGNOSTIC KIT OF SARS-COV-2 EARLY DETECTION
ELYSIUM & BIOMOL
We have developed a diagnostic KIT to identify the Covid19 "Spreaders" positive to sgN biomarker of active and infective virus
THERAPEUTICS
AGAINST NEW EMERGENT VIRUSES AND INFECTIONS
We have identified three drugs with anti-viral and anti-micotic activities with different mechanism of actions:
2-PI-7 (A caloxin derivative small molecule) against PMCA1-ATP2B1) (NEWS)
3-ELYSIVIR, a small molecule against SARS-COV-2 and new genome RNA viruses (HIV, Zika, Dengue) . Results are now in manuscript submission.
AGAINST METASTATIC CANCER (Breast and Brain):
N.1 anti-Prune1 small molecules developed and tested in animal models of metastatic cancer (Breast and Brain). An International patent is granted at the European Patent Office.
ELYSIUM CELL BIO ITA
SOCIAL
ADDRESS
via Gaetano Salvatore, 486
Napoli
80145
Italia
Presso CEINGE Biotecnologie Avanzate Franco Salvatore scarl
P.I. 10204541212